LiveWorld Expands Board of Directors, Adding Healthcare & Tech Executive Carl Gustin

Marketing innovator Mr. Gustin to drive LiveWorld’s AI-powered growth

Carl Gustin, Chief Strategy & Marketing Officer, SpeciCare

Carl Gustin appointed to LiveWorld Board of Directors

CAMPBELL, Calif., and NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — LiveWorld, Inc. (OTC Markets: LVWD), a leading social-first digital agency specializing in compliance, engagement and insight solutions for healthcare and pharma brands, today announced the appointment of Carl Gustin to its Board of Directors. Gustin brings broad experience in healthcare, technology, and AI-driven business transformation, positioning LiveWorld for accelerated growth and innovation in the pharmaceutical and healthcare sectors.

Gustin currently serves as Chief Strategy & Marketing Officer at SpeciCare – New Options in Cancer Care. A recognized industry leader, he has held senior marketing and business management roles across global corporations, emerging brands, and agencies, shaping market strategies that have driven substantial business growth. His tenure as Chief Marketing Officer at Kodak saw him lead the company’s digital transformation. Additionally, he played a pivotal role in launching Apple’s first PowerBook and has been honored as an Ad Age Top 50 Marketer.

“Carl’s expertise in healthcare, technology, and driving the application and integration of AI-driven business and marketing solutions makes him an invaluable addition to LiveWorld’s Board,” said Peter Friedman, Chairman and CEO of LiveWorld. “His strategic insights and leadership will strengthen our ability to expand our client portfolio, bring to market innovative AI solutions, and further establish LiveWorld as a key player in the healthcare and pharma marketing space.”

Gustin’s appointment reinforces LiveWorld’s commitment to evolving its AI-driven solutions and deepening its footprint in the healthcare industry. With over 28 years of experience in transforming customer relationships through digital engagement, LiveWorld continues to empower leading pharmaceutical and healthcare brands with innovative, compliant, and effective social media strategies.

For more information about LiveWorld and its Board of Directors, visit www.liveworld.com.

About LiveWorld:
LiveWorld is a social-first digital agency that unlocks the full potential of social media to transform customer relationships through integrated compliance, engagement, and insight solutions. We provide brand marketers with bold, strategy-driven creative that captivates audiences, along with AI-powered software, social moderation, and compliance solutions tailored for healthcare and pharma.

With over 28 years of expertise, LiveWorld delivers emotion-driven behavior change through digital campaigns with a human touch. Our clients include the number one brands in pharmaceuticals, healthcare, and financial-travel services. LiveWorld is headquartered in Campbell, California, with an additional office in New York City.

For media inquiries, please contact:
Matthew Hammer
mhammer@liveworld.com
(737) 212-9739

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2734e79a-51b1-484c-b675-ea1873bb93ce

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

2 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

2 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

2 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

2 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

2 hours ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

2 hours ago